SHS is an independent private equity company focus on investments in the MedTech and Life Sciences sectors.
Business Model:
Revenue: $0
Employees: 0-0
Address: Bismarckstraße 12
City: Tuebingen
State: baden-württemberg
Zip: 72072
Country: DE
SHS, founded in 1993, is an independent private equity company. Their focus is on investments in the MedTech, Life Sciences, Diagnostics and Digital Health sectors. SHS is one of the leading healthcare growth investors in Germany and has launched five generations of funds since its foundation and invested in over 50 companies. Investments are currently being made by the fourth and fifth generations of funds. The latest fund, SHS V, is still open for subscription until end of June 2019. They do invest in young, high-growth companies as well as realize small buyouts and growth financings of established companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2004 | CryLaS | Venture Round | - |
10/2011 | numares HEALTH | Venture Round | 9.5M |
12/2009 | numares HEALTH | Venture Round | 5.7M |
10/2011 | Miracor Medical | Series B | 10M |
7/2008 | Biontis | Venture Round | - |
9/2015 | NDD Medizintechnik | Venture Round | - |
2/2020 | Selfapy | Venture Round | 0 |
8/2019 | GNA Biosolutions | Series C | 0 |
5/2021 | Incision | Series A | 0 |
8/2010 | Phenox | Venture Round | - |
6/2016 | Tyromotion | Seed Round | - |
9/2014 | TRI Dental Implants | Venture Round | - |
12/2014 | Vimecon | Venture Round | - |
3/2015 | GNA Biosolutions | Series B | 0 |
4/2017 | CoreMedic GmbH | Venture Round | - |
3/2023 | Simulands | Seed Round | 10.6M |
3/2006 | Micropelt | Series A | 6M |
3/2015 | Les Delices des 7 Vallees | Venture Round | - |
12/2018 | evitria | Venture Round | - |
5/2021 | Incision | Series A | 6.1M |
4/2020 | Neuro Event Labs | Series A | 0 |
2/2020 | Blazejewski MEDI-TECH | Venture Round | - |
5/2019 | Betterguards Technology GmbH | Venture Round | - |
11/2019 | Single Use Support | Venture Round | - |
4/2008 | c-LEcta | Series C | - |
9/2020 | Salvia BioElectronics | Series A | 0 |
4/2022 | Dr.Dropin | Venture Round | 0 |
11/2021 | PathoQuest | Series B | 0 |
11/2021 | PathoQuest | Series B | 17.4M |
6/2016 | AOT - Advanced Osteotomy Tools | Series C | 11.4M |
2/2015 | AOT - Advanced Osteotomy Tools | Venture Round | - |
6/2015 | Arzneimittelwerk Warngau | Series B | 7.9M |
9/2016 | Emerging Implant Technologies | Venture Round | - |
1/2018 | Miracor Medical | Series D | 0 |
10/2016 | Miracor Medical | Series C | 0 |
1/2015 | Miracor Medical | Series B | 5.3M |
7/2016 | Arzneimittelwerk Warngau | Series C | 6.6M |
4/2022 | Dr.Dropin | Venture Round | 0 |
11/2021 | PathoQuest | Series B | 0 |
5/2021 | Incision | Series A | 0 |
9/2020 | Salvia BioElectronics | Series A | 0 |
4/2020 | Neuro Event Labs | Series A | 0 |
2/2020 | Blazejewski MEDI-TECH | Venture Round | - |
2/2020 | Selfapy | Venture Round | 0 |
11/2019 | Single Use Support | Venture Round | - |
8/2019 | GNA Biosolutions | Series C | 0 |
5/2019 | Betterguards Technology GmbH | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|